Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome evaluation of its efficacy using NIH-CPSI after 4-week treatment

Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome : evaluation of its efficacy using NIH-CPSI after 4-week treatment

We investigated the effect of naftopidil an alpha1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS). Patients who had given informed consent were treated with naftopidil (daily 50 mg), and wer...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 56(2010), 4 vom: 30. Apr., Seite 215-9
Auteur principal: Suzuki, Akira (Auteur)
Autres auteurs: Ohinata, Mitsuru, Fujishima, Mikihiko, Hirano, Shigeru, Kudou, Takuji, Funaki, Hiroyoshi, Akasaka, Toshiyuki
Format: Article
Langue:Japanese
Publié: 2010
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN